Pangenomic Health Inc. operates as a precision health company in Canada. The company offers Nara App, a telehealth mental health app that provides users with personalized information about non-pharmaceutical alternatives to address mental health concerns; and Mindleap, a telehealth platform, which provides various tools and resources to help individuals understand and improve their inner wellness. It also provides MUJN, a clinical decision support platform that offers health practitioners with access to the consumer's mobile app data and their diagnostic reports. In addition, the company offers vitamin D assessment services and BDNF (brain-derived neurotrophic factor) mental health biomarker health assessment service. The company was formerly known as Zetta Capital Corp. and changed its name to Pangenomic Health Inc. in December 2021. The company was incorporated in 2015 and is based in Vancouver, Canada.
Часто задаваемые вопросы
В каком секторе работает Pangenomic Health Inc. (NARA)?
Pangenomic Health Inc. относится к сектору Здравоохранение.
Какова текущая цена акций Pangenomic Health Inc. (NARA)?
По последним данным, цена акций Pangenomic Health Inc. составляет 0,35 CA$, предыдущее закрытие — 0,40 CA$. За последнюю торговую сессию акции Pangenomic Health Inc. снизились на -0,05 CA$, что соответствует падению на -12,5%.
Выплачивает ли Pangenomic Health Inc. (NARA) дивиденды?
Нет, Pangenomic Health Inc. не выплачивает дивиденды.
Какой бета-коэффициент (волатильность) у Pangenomic Health Inc. (NARA)?
У компании Pangenomic Health Inc. бета -0.804, что указывает на более низкую волатильность по сравнению с рынком в целом.
